Business Description
Vetoquinol SA
ISIN : FR0004186856
Total Employee Number:
2,497Compare
Compare
Traded in other countries / regions
VETO.France8JM.Germany0O1O.UKVETOF.USA IPO Date
2009-11-04Description
Vetoquinol SA operates is a France-based firm serving in the healthcare market. Its focus lies on developing and marketing veterinary drugs mainly in the European region and to a certain extent in America and Asia. Its portfolio of drugs entails anti-infectives, anti- pain inflammatory drugs, cardiovascular and nephrology treatment intended mainly for pets and livestock.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 14.46 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | 0.13 | |||||
Interest Coverage | 62.69 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 4.53 | |||||
Beneish M-Score | -2.59 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.3 | |||||
3-Year EBITDA Growth Rate | 0.5 | |||||
3-Year EPS without NRI Growth Rate | 8.6 | |||||
3-Year FCF Growth Rate | 9 | |||||
3-Year Book Growth Rate | 7.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 6.62 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 3.37 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
9-Day RSI | 100 | |||||
14-Day RSI | 100 | |||||
6-1 Month Momentum % | 3.76 | |||||
12-1 Month Momentum % | 3.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.08 | |||||
Quick Ratio | 2.26 | |||||
Cash Ratio | 1.49 | |||||
Days Inventory | 334.48 | |||||
Days Sales Outstanding | 61.46 | |||||
Days Payable | 183.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 3.6 | |||||
3-Year Average Share Buyback Ratio | 0.6 | |||||
Shareholder Yield % | 3.21 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 74.73 | |||||
Operating Margin % | 14.97 | |||||
Net Margin % | 10.91 | |||||
EBITDA Margin % | 22.07 | |||||
FCF Margin % | 9.83 | |||||
OCF Margin % | 13.78 | |||||
ROE % | 9.92 | |||||
ROA % | 7.7 | |||||
ROIC % | 13.73 | |||||
3-Year ROIIC % | -2.47 | |||||
ROC (Joel Greenblatt) % | 44.56 | |||||
ROCE % | 13.52 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 14.47 | |||||
Forward PE Ratio | 15.64 | |||||
PE Ratio without NRI | 14.53 | |||||
Shiller PE Ratio | 18.07 | |||||
Price-to-Owner-Earnings | 9.99 | |||||
PEG Ratio | 3.09 | |||||
PS Ratio | 1.58 | |||||
PB Ratio | 1.41 | |||||
Price-to-Tangible-Book | 2.13 | |||||
Price-to-Free-Cash-Flow | 15.99 | |||||
Price-to-Operating-Cash-Flow | 11.43 | |||||
EV-to-EBIT | 7.67 | |||||
EV-to-EBITDA | 5.39 | |||||
EV-to-Revenue | 1.19 | |||||
EV-to-FCF | 12.18 | |||||
Price-to-GF-Value | 0.84 | |||||
Price-to-Projected-FCF | 0.92 | |||||
Price-to-DCF (Earnings Based) | 0.94 | |||||
Price-to-DCF (FCF Based) | 1.06 | |||||
Price-to-Median-PS-Value | 0.85 | |||||
Price-to-Graham-Number | 1.17 | |||||
| Price-to-Net-Current-Asset-Value | 2.91 | |||||
| Price-to-Net-Cash | 17.04 | |||||
Earnings Yield (Greenblatt) % | 13.04 | |||||
FCF Yield % | 6.18 | |||||
Forward Rate of Return (Yacktman) % | 9.35 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:VETOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vetoquinol SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 611.034 | ||
| EPS (TTM) ($) | 5.747 | ||
| Beta | -0.9263 | ||
| 3-Year Sharpe Ratio | 0.49 | ||
| 3-Year Sortino Ratio | 13.54 | ||
| Volatility % | 3.84 | ||
| 14-Day RSI | 100 | ||
| 14-Day ATR ($) | 0.00013 | ||
| 20-Day SMA ($) | 90.8 | ||
| 12-1 Month Momentum % | 3.76 | ||
| 52-Week Range ($) | 87.51 - 90.8 | ||
| Shares Outstanding (Mil) | 11.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vetoquinol SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vetoquinol SA Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| EUR 0.930000 Cash Dividend | 2026-06-03 | 90.80 (+0.00%) | ||
| EUR 0.890000 Cash Dividend | 2025-06-04 | 87.51 (+0.00%) |
Show
Entries
Vetoquinol SA Frequently Asked Questions
What is Vetoquinol SA(VETOF)'s stock price today?
The current price of VETOF is $90.80. The 52 week high of VETOF is $90.80 and 52 week low is $87.51.
When is next earnings date of Vetoquinol SA(VETOF)?
The next earnings date of Vetoquinol SA(VETOF) is .
Does Vetoquinol SA(VETOF) pay dividends? If so, how much?
Vetoquinol SA(VETOF) does not pay dividend.
Guru Commentaries on OTCPK:VETOF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Vetoquinol SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers